Retraction Note to: Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer’s disease (Aging Clinical and Experimental Research, (2009), 21, 4-5, (277-281), 10.1007/BF03324916);Prevention of hip fractures by exposure to sunlight and pharmacotherapy in patients with Alzheimer's disease

Aging Clinical and Experimental Research

Volumn 21, Issue 4-5, 2009, Pages 277-281

  Iwamoto, Jun ^a   Sato, Yoshihiro ^b   Tanaka, Kiyoshi ^c   Takeda, Tsuyoshi ^a   Matsumoto, Hideo ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Mitate Hospital   (Japan)

^c KYOTO WOMEN'S UNIVERSITY   (Japan)

Author keywords

Alzheimer's disease; Hip fracture; Mortality; Vitamin D; Vitamin K

Indexed keywords

CALCIUM; ERGOCALCIFEROL; MENATETRENONE; OSTEOCALCIN; PLACEBO; RISEDRONIC ACID; VITAMIN D;

ADD ON THERAPY; AGED; ALZHEIMER DISEASE; ARTICLE; BONE ATROPHY; BONE DENSITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FEMALE; HIP FRACTURE; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; METACARPAL BONE; OSTEOLYSIS; PHOTOTHERAPY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SUN EXPOSURE; SUNLIGHT; TREATMENT OUTCOME; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY; VITAMIN SUPPLEMENTATION;

EID: 73849138165     PISSN: 15940667     EISSN: 17208319     Source Type: Journal    
DOI: 10.1007/s40520-018-0977-y     Document Type: Erratum

References (31)

1. Scafato E, Gandin C, Farchi G et al. Italian Project on Epidemiology of Alzheimer's disease (I.PR.E.A.): Study design and methodology of cross-sectional survey. Aging Clin Exp Res 2005; 17: 29-34. (Pubitemid 43073056)
2. Bianchetti A, Ranieri P, Margiotta A, Trabucchi M. Pharmacological treatment of Alzheimer's Disease. Aging CBn Exp Res 2006; 18: 158-162
3. Johansson C, Skoog I. A population-based study on the association between dementia and hip fractures in 85-year olds. Aging Clin Exp Res 1996; 8: 189-196 (Pubitemid 26291554)
4. Melton U III, Beard CM, Kokmen E, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1994; 42: 614-619 (Pubitemid 24180960)
5. van Staa TP, Leufkens HG, Cooper C. Utility of medical and drug history in fracture risk prediction among men and women. Bone 2002; 31: 508-514 (Pubitemid 35189541)
6. Buchner DM, Larson EB. Falls and fractures in patients with Alzheimer-type dementia. JAMA 1987; 257: 1492-1495
7. Weiler I, Schatzker J. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 2004; 14: 319-324 (Pubitemid 38737324)
8. Nurmi I, Narinen A, Luthje P, Tanninen S. Cost analysis of hip fracture treatment among the elderly for the public health services: a 1-year prospective study in 106 consecutive patients. Arch Orthop Trauma Surg 2003; 123: 551-554 (Pubitemid 38008355)
9. Holmes J, House A. Psychiatric illness predicts poor outcome after surgery for hip fracture: a prospective cohort study. Psychol Med 2000; 30: 921-929 (Pubitemid 30623977)
10. Matsueda M, Ishii Y. The relationship between dementia score and ambulatory level after hip fracture in the elderly. Am J Orthop 2000; 29: 691-693
11. Morrison RS, Siu AL. Mortality from pneumonia and hip fractures in patients with advanced dementia. JAMA 2000; 284: 2447-2448
12. Nightingale S, Holmes J, Mason J, House A. Psychiatric illness and mortality after hip fracture. Lancet 2001; 357: 1264-1265 (Pubitemid 32539058)
13. Sato Y, Kanoko T, Satoh K, Iwamoto J. Risk factors for hip fracture among elderly patients with Alzheimer's disease. J Neurol Sci 2004; 223: 107-112 (Pubitemid 39164351)
14. Sato Y, Asoh T, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 1998; 23: 555-557 (Pubitemid 28529461)
15. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehabil 2005; 86: 576-581 (Pubitemid 40326644)
16. Sato Y, Iwamoto J, Kanoko T, Satoh K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2005; 20: 1327-1333 (Pubitemid 41033516)
17. 2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone 2005; 36: 61-68 (Pubitemid 40128275)
18. Sato Y, Kanoko T, Satoh K, Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 2005; 165: 1737-1742 (Pubitemid 41138961)
19. Epstein S. Is cortical bone hip? What determines cortical bone properties? Bone 2007; 41 (Suppl 1): S3-8.
20. Iwamoto J, Sato Y, Takeda T, Matsumoto H. Hip fracture protection by alendronate treatment in postmenopausal women with osteoporosis: a review of the literature. Clin Inter Aging 2008; 3: 1-7.
21. Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD. Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 2002; 87: 1586-1592 (Pubitemid 34615244)
22. Beadle PC. Sunlight, ozone and vitamin D. Br J Dermatol 1977; 97: 585-591
23. Lester E, Skinner RK, Foo AY, Lund B, Sorensen OH. Serum 25-hydroxyvitamin D levels and vitamin D intake in healthy young adults in Britain and Denmark. Scand J Clin Lab Invest 1980; 49: 145-150 (Pubitemid 10132137)
24. Sato Y, Inose M, Higuchi I, Higuchi F, Kondo I. Changes in the supporting muscles of the fractured hip in elderly women. Bone 2002; 30: 325-330 (Pubitemid 34048326)
25. Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC et al. Effect of vitamin D on falls: a meta-analysis. JAMA 2004; 291: 1999-2006.
26. Bischoff-Ferrari HA, Willett WC, Wong JB, Giovannucci E, Dietrich T, Dawson-Hughes B. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005; 293: 2257-2264 (Pubitemid 40629192)
27. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest 1993; 91: 1769-1774 (Pubitemid 23127383)
28. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three-year follow-up study. Bone 1996; 18: 487-488 (Pubitemid 26152313)
29. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab 1997; 82: 719-724 (Pubitemid 27106576)
30. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int 2007; 18: 963-972 (Pubitemid 46889558)
31. Runge M, Hunter G. Determinants of musculoskeletal frailty and the risk of falls in old age. J Musculoskelet Neuronal Interact 2006; 6: 167-173 (Pubitemid 44193217)